Commentary on Oeckl et al., “Serum Beta‐Synuclein Is Higher in Down Syndrome and Precedes Rise of pTau181”
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Neurology"
DOI: 10.1002/ana.26414
Abstract: Commentary on Oeckl et al., “Serum Beta-Synuclein Is Higher in Down Syndrome and Precedes Rise of pTau181” People with Down syndrome (DS) develop Alzheimer disease (AD) neuropathology by the time they are 40 years of… read more here.
Keywords: commentary oeckl; serum; synuclein; age ... See more keywords